Post PCI FFR Reduces MACE

Original Title: Utilizing Post-Intervention Fractional Flow Reserve to Optimize Acute Results and the Relationship to Long-Term Outcomes

Reference: Shiv K. Agarwal, et al. JACC Cardiovascular Intervention 2016;9:1022-31

 

Courtesy of Dr. Carlos Fava.

 

FFR post PCIFractional flow reserve has shown benefits and it is considered the gold standard to assess intermediate lesions (Class IA), but its use post PCI has not been evaluated yet.

574 patients with 664 lesions were analyzed; 45% had a history of diabetes, 48% multivessel disease and 45% diffuse disease.

Previous obstruction degree by quantitative angiography was 73±15%, 96% with FFR ≤0.80 and 73% FFR ≤0.75, regardless adenosine administration technique.

After PCI with angiographically satisfactory results, 21% (143 lesions) presented a suboptimal FFR ≤0.80 (0.75±0.05). After a second intervention to this group (post balloon dilation, subsequent stent implantation, or IVUS or OCT lesion assessment) FFR increased to 0.87±0.06 (p<0.0001). 9% continued with suboptimal FFR.

This was associated to longer procedural and fluoroscopy time, but not with more contrast.

Follow up was at 31 months with 19% of patients presenting some event (62 death by any cause, 12 MI, and 60 revascularizations).

MACE predictors were ACS, diffuse lesions and ≤0.86 final FFR.

In ROC curve analyzis, final FFR cutoff value predictor of MACE was ≤0.86 (23% vs. 17% p=0.02), for death ≤0.87 (13.5% vs. 9% p=0.03) and TVR ≤0.85 (12% vs. 8% p=0.03).

Conclusion

Post PCI FFR reclassifies 20% of PCI with satisfactory results, requiring more intervention to achieve complete functional revascularization at the time of index procedure. Post PCI FFR is an independent predictor of long term evolution.

Editorial Comment

This analyzis shows the concept of PCI “Functional Optimization”, because 20% of patients present ischemia after a satisfactory angiography.

Ideally, we should identify the groups that could benefit from this strategy in order not to unnecessarily prolong procedures and to save costs.

Courtesy of Dr. Carlos Fava. Favaloro Foundation, Buenos Aires, Argentina.

We value your opinion. You are more than welcome to leave your comments, thoughts, questions or any ideas here below.

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

1-Year Outcomes of US TAVR Registry with 5th Generation Balloon Expandable Valves

The use of transcatheter aortic valve replacement (TAVR) has extended to younger patients with lower risk severe aortic stenosis (AS) and therefore the improvement...

EuroSMR Registry: Edge-to-Edge Mitral Treatment with 5-Year Outcomes

Cardiomyopathies and left atrial enlargement can lead to secondary mitral regurgitation (SMR). This condition is associated with ventricular dysfunction, causing heart failure, hospitalization, and...

TricValve Transcatheter Bicaval Valve System for Severe Tricuspid Insufficiency: Events at One Year

TricValve is the first bicaval valve system to obtain CE-Mark approval. This device heterotopic device eliminates tricuspid insufficiency reflux into the venous system, reducing...